CSTL ▼ -5.0% - Castle Biosciences, Inc. $CSTL CSTL - ACG 2026 Data Show TissueCypher® Identifies Elevated Risk of Progression Beyond Pathology Findings in Barrett's Esophagus 12-OCT-2026 04:30 PM ET